Top 20 genes with significantly decreased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

Roughness change in means of Ra (nm) and RMS (nm) for both tested systems. (different capital superscript letters indicate within group significancy, different lower-case superscri... by Beliz Özel (16475132)

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

Subjects:

Metabolites elevated significantly in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

Case. by Seungyoon Paik (14659575)

Subjects:

Top 20 genes with significantly increased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

Clinical and radiologic features of patients with Covid-19 and control group. by Sam Alahyari (12645313)

Subjects:

Species richness decreases significantly with increasing percent disturbance. by Catherine L. Cardelús (6429320)

Comparison of the statistical significance between t-tests with C₁ = 40 and CTOT with C₁ = 32. by Wei Zhuang (146641)

Emergency department admissions by cause of admission (Clinical Classification Software category -CCS) in 2020 vs 2018–19 (average); percentage changes and 95% CIs (Poisson regress... by Vieri Lastrucci (5787392)

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Minimum number of patients to detect a significant protective effect of a drug against BRAO-induced GCL thickness loss. by Thomas R. Shearer (9761486)

DataSheet_1_Changes and significance of gut microbiota in children with focal epilepsy before and after treatment.docx by Changci Zhou (14052459)

“…At the phyla level, the relative abundance of Actinobacteria in the pre-treatment subgroup was significantly higher than that in the control group, which decreased significantly after 3 months of treatment and showed no significant difference between the control group. …”

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Serologic changes in 8 representative cases of sub-serostatus and clinical interpretation groups. by Ei Kinai (212480)

Clinical data of the control and CoA cases in our cohort. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Proportion of patients with significant difficulties on the clinical scale (% above cut-off) by disability profile. by Anne-Sophie Lambert (3510560)